Skip to main content
. 2019 Apr 2;9:5473. doi: 10.1038/s41598-019-41837-3

Figure 1.

Figure 1

Schematic diagram depicting overall study design. The study corresponded to randomized, double-blind, four-arm parallel-group, placebo-controlled and dose-response relationship. Post-study safety assessment (Haemoglobin, Total Count, Differential Count, Platelet count, and biochemical parameters –SGOT, SGPT, Bilirubin, Creatinine, and Urea) was also performed at the end of study (Day 210).